Core Insights - The core point of the article is the disclosure of institutional and public fund holdings in Deguan New Materials (001378.SZ) as of the third quarter of 2025, highlighting a slight decrease in institutional ownership compared to the previous quarter [1]. Institutional Holdings - As of October 28, 2025, two institutional investors hold a total of 51.9682 million shares of Deguan New Materials, representing 38.98% of the total share capital [1]. - The institutional investors include Guangdong Deguan Group Co., Ltd. and a collective asset management plan from China Merchants Securities Asset Management [1]. - Compared to the previous quarter, the total institutional holding percentage decreased by 0.12 percentage points [1]. Public Fund Holdings - In this reporting period, 49 public funds were disclosed, which were not reported in the previous quarter [1]. - Notable public funds include Jianxin Flexible Allocation Mixed A, Southern Big Data 300 Index A, and others [1].

Core Insights - Sifangda (300179.SZ) released its Q3 2025 financial report on October 23, 2025, indicating a total of 1 institutional investor holding shares, amounting to 2.3621 million shares, which represents 0.49% of the total share capital [1] - The institutional holding ratio increased by 0.34 percentage points compared to the previous quarter [1] Institutional Investors - The only institutional investor disclosed is Agricultural Bank of China - Fortune Growth Two-Year Regular Open Mixed Securities Investment Fund [1] - The total institutional holding ratio is now 0.49% [1] Public Funds - One new public fund was disclosed this period, which is the Fortune Growth Two-Year Regular Open Mixed Fund [1] - A total of 17 public funds were not disclosed compared to the previous quarter, including notable funds such as Guotai CSI Machine Tool ETF, CSI 2000, and others [1]

Core Viewpoint - Zhongke Electric experienced a 5.16% increase in stock price, reaching 24.27 CNY per share, with a trading volume of 1.133 billion CNY and a turnover rate of 8.39%, resulting in a total market capitalization of 16.635 billion CNY [1] Company Overview - Hunan Zhongke Electric Co., Ltd. was established on April 6, 2004, and listed on December 25, 2009. The company is primarily engaged in the research, development, production, sales, and service of industrial magnetic application technologies and products [1] - The main revenue composition includes: 92.50% from lithium battery anode materials, 8.53% from electromagnetic equipment, and 2.71% from other sources [1] Shareholder Insights - Southern Fund's Southern CSI 1000 ETF (512100) is among the top ten circulating shareholders of Zhongke Electric, having increased its holdings by 1.1853 million shares in the second quarter, totaling 6.3232 million shares, which represents 1.08% of circulating shares [2] - The estimated floating profit from this investment is approximately 7.5246 million CNY [2] Fund Performance - The Southern CSI 1000 ETF (512100) was established on September 29, 2016, with a current scale of 64.953 billion CNY. Year-to-date returns are 25.67%, ranking 1948 out of 4220 in its category, while the one-year return is 67.42%, ranking 1298 out of 3814 [2] - The fund manager, Cui Lei, has a tenure of 6 years and 323 days, with total assets under management of 94.976 billion CNY. The best fund return during this period is 139.52%, while the worst is -15.93% [3] Additional Fund Insights - Another fund, Southern Big Data 300 Index A (001420), holds 160,800 shares of Zhongke Electric, accounting for 1.03% of the fund's net value, ranking as the fifth-largest holding [4] - The estimated floating profit from this position is about 191,400 CNY [4] - The Southern Big Data 300 Index A was established on June 24, 2015, with a current scale of 2.17 billion CNY. Year-to-date returns are 36.29%, ranking 1259 out of 4220, while the one-year return is 83.37%, ranking 900 out of 3814 [4] - The fund manager, Xie Rui, has a tenure of 3 years and 220 days, managing total assets of 2.012 billion CNY, with the best return during this period being 21.33% and the worst being -0.16% [5]

Core Viewpoint - On September 19, Xingqi Eye Pharmaceutical experienced a decline of 5.1%, with a stock price of 67.96 yuan per share, a trading volume of 872 million yuan, a turnover rate of 6.64%, and a total market capitalization of 16.674 billion yuan [1] Company Overview - Xingqi Eye Pharmaceutical Co., Ltd. is located in Shenyang, Liaoning Province, and was established on March 24, 1977, with its listing date on December 8, 2016 [1] - The company's main business involves the research, production, and sales of ophthalmic drugs, with revenue composition as follows: eye drops 82.15%, gel/eye ointment 16.70%, and others 1.15% [1] Shareholder Information - Southern Fund's Southern CSI 500 ETF (510500) is among the top ten circulating shareholders of Xingqi Eye Pharmaceutical, having increased its holdings by 764,100 shares in the second quarter, totaling 2.5163 million shares, which represents 1.34% of the circulating shares [2] - The estimated floating loss for the ETF today is approximately 9.1846 million yuan [2] - The Southern CSI 500 ETF was established on February 6, 2013, with a latest scale of 113.438 billion yuan, and has achieved a year-to-date return of 27.4% [2] Fund Performance - The Southern Big Data 300 Index A (001420) holds 47,800 shares of Xingqi Eye Pharmaceutical, accounting for 0.93% of the fund's net value, ranking as the seventh largest holding [3] - The estimated floating loss for this fund today is about 174,300 yuan [3] - The Southern Big Data 300 Index A was established on June 24, 2015, with a latest scale of 2.17 billion yuan, and has achieved a year-to-date return of 37% [3]